Chime Biologics Announces Strategic Collaboration with Beijing Libang Pharmaceutical on Global Blinatumomab Biosimilar Program

SunRock Biopharma and Chime Biologics Announce Strategic Collaboration to Advance Development of Anti-CCR9 Antibody SRB5

Frederic Bouvier Joins Chime Biologics as Vice President of Business Development, Overseas (Europe) and Head of Global Strategy & Partnerships

categoryidArraymk-test